Moneycontrol Bureau
Ajanta Pharma shares gained 2 percent intraday Tuesday after its subsidiary has launched Memantine hydrochloride tablets in the US.
Memantine hydrochloride is an anti-dementia drug and is a bioequivalent generic version of Namenda.
Ajanta said it has launched the drug in two strengths 5mg and 10mg tablets.
So far, United States Food & Drug Administration has granted Ajanta Pharma 10 final approvals and 2 tentative approvals for its abbreviated new drug application, it said, adding another 14 ANDAs are pending approval from the USFDA.
At 11:27 hours IST, the scrip of Ajanta Pharma was quoting at Rs 1,589.10, up Rs 27.85, or 1.78 percent on Bombay Stock Exchange.Posted by Sunil Shankar Matkar
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
